Equities

DaShenLin Pharmaceutical Group Co Ltd

603233:SHH

DaShenLin Pharmaceutical Group Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (CNY)15.30
  • Today's Change-0.78 / -4.85%
  • Shares traded9.81m
  • 1 Year change-40.05%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments3,0393,8682,357
Total Receivables, Net1,8671,5141,110
Total Inventory4,1813,8723,630
Prepaid expenses292698226
Other current assets, total1,419717545
Total current assets10,79810,6707,868
Property, plant & equipment, net7,3436,1455,727
Goodwill, net3,0242,3642,060
Intangibles, net1,880701676
Long term investments215177235
Note receivable - long term------
Other long term assets------
Total assets24,12320,84117,336
LIABILITIES
Accounts payable2,7462,7722,053
Accrued expenses765827500
Notes payable/short-term debt5,0774,1582,946
Current portion long-term debt/capital leases1,056982906
Other current liabilities, total1,811969771
Total current liabilities11,4549,7087,176
Total long term debt4,7084,2524,204
Total debt10,8409,3918,056
Deferred income tax------
Minority interest1,109652457
Other liabilities, total291820
Total liabilities17,29914,62911,857
SHAREHOLDERS EQUITY
Common stock1,139949791
Additional paid-in capital1,3551,5371,643
Retained earnings (accumulated deficit)4,1703,5732,933
Treasury stock - common(30)(37)(78)
Unrealized gain (loss)------
Other equity, total190190190
Total equity6,8246,2125,479
Total liabilities & shareholders' equity24,12320,84117,336
Total common shares outstanding1,1371,1361,136
Treasury shares - common primary issue1.852.733.43
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.